Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy.
Watts J, Madarang E, Abbott D, Hart P, Sohalski C, Zoso A, Dell-Martin J, Belachew A, Amaya ML, Kent A, McMahon C, Schwartz M, Sekeres MA, Smith C, Bradley T, Taylor J, Chandhok N, Venugopal S, Jordan C, Berg M, Haag M, Willard N, Aisner D, Schowinsky J, Pan Z, Zhang J, Gutman JA, Pollyea DA.
Watts J, et al. Among authors: hart p.
Haematologica. 2026 Feb 26. doi: 10.3324/haematol.2025.300374. Online ahead of print.
Haematologica. 2026.
PMID: 41742869
Free article.